URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes

Trends in Microbiology

Volumn 11, Issue 2, 2003, Pages 69-73

  Staab, Janet F ^a   Sundstrom, Paula ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ALBICANS; CANDIDIASIS; FUNGAL GENE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE STRUCTURE; LETHALITY; MARKER GENE; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; URA3 GENE; VIRULENCE; VIRUS GENOME;

ANIMALS; CANDIDA ALBICANS; ENZYME ACTIVATION; FUNGAL PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; GENETIC MARKERS; MICE; MODELS, GENETIC; MUTAGENESIS, INSERTIONAL; OROTIDINE-5'-PHOSPHATE DECARBOXYLASE; VIRULENCE FACTORS;

ANIMALIA; CANDIDA; CANDIDA ALBICANS;

EID: 0037322293     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(02)00029-X     Document Type: Review

References (19)

1. Kurtz M.B., et al. Integrative transformation of Candida albicans, using a cloned Candida ADE2 gene. Mol. Cell. Biol. 6:1986;142-149.
2. Alani E., Kleckner N. A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics. 116:1987;541-545.
3. Fonzi W.A. Isogenic strain construction and gene mapping in Candida albicans. Genetics. 134:1993;717-728.
4. Garcia M.G., et al. Isolation of a Candida albicans gene, tightly linked to URA3, coding for a putative transcription factor that suppresses a Saccharomyces cerevisiae aft1 mutation. Yeast. 18:2001;301-311.
5. Kirsch D.R., Whitney R.R. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect. Immun. 59:1991;3297-3300.
6. Bain J.M., et al. Ura-status-dependent adhesion of Candida albicans mutants. FEMS. 204:2001;323-328.
7. Lay J., et al. Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect. Immun. 66:1998;5301-5306.
8. Myers K.K., et al. Use of URA3 as a reporter of gene expression in C. albicans. Curr. Genet. 27:1995;243-248.
9. Yoshimoto A., et al. Orotidylate decarboxylase (yeast). Methods Enzymol. 51:1978;74-79.
10. Antley P.P., Hazen K.C. Role of yeast cell growth temperature on Candida albicans virulence in mice. Infect. Immun. 56:1988;2884-2890.
11. Ashman R.B., et al. Murine candidiasis: sex differences in the severity of tissue lesions are not associated with levels of serum C3 and C5. Immunol. Cell Biol. 69:1991;7-10.
12. Odds F.C., et al. Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host. Microbiology. 146:2000;1881-1889.
13. Sundstrom P., et al. Reevaluation of the role of HWP1 in systemic candidiasis by use of Candida albicans strains with selectable marker URA3 targeted to the ENO1 locus. Infect. Immun. 70:2002;3281-3283.
14. Postlethwait P., Sundstrom P. Genetic organization and mRNA expression of enolase genes of Candida albicans. J. Bacteriol. 177:1995;1772-1779.
15. Staab J.F., et al. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 283:1999;1535-1538.
16. Bahn Y.S., Sundstrom P. CAP1, an adenylate cyclase-associated protein gene, regulates bud-hypha transitions, filamentous growth, and cyclic AMP levels and is required for virulence of Candida albicans. J. Bacteriol. 183:2001;3211-3223.
17. Felk A., et al. Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect. Immun. 70:2002;3689-3700.
18. Kelly R., et al. One-step gene disruption by cotransformation to isolate double auxotrophs in Candida albicans. Mol. Gen. Genet. 214:1988;24-31.
19. Palmieri L., et al. Identification of the yeast ARG-11 gene as a mitochondrial ornithine carrier involved in arginine biosynthesis. FEBS Lett. 410:1997;447-451.